Cite
Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.
MLA
Liu, Huimin, et al. “Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.” Disease Markers, Dec. 2020, pp. 1–11. EBSCOhost, https://doi.org/10.1155/2020/8814841.
APA
Liu, H., Li, Y., Gao, F., Meng, P., Yu, H., Wu, T., Zhou, Y., Jiang, Y., & Wang, X. (2020). Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure. Disease Markers, 1–11. https://doi.org/10.1155/2020/8814841
Chicago
Liu, Huimin, Yuxin Li, Fangyuan Gao, Peipei Meng, Hao Yu, Tong Wu, Yang Zhou, Yuyong Jiang, and Xianbo Wang. 2020. “Serum Clusterin: A Potential Marker for Assessing the Clinical Severity and Short-Term Prognosis of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.” Disease Markers, December, 1–11. doi:10.1155/2020/8814841.